U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping over 50 points on Friday.
The Dow traded up 0.19% to 33,608.80 while the NASDAQ fell 0.50% to 11,089.07. The S&P 500 also rose, gaining, 0.03% to 3,947.70.
Also check this: Investor Optimism Declines After US Stocks Settle Lower
Leading and Lagging Sectors
Utilities shares rose by 1.4% on Friday. Leading the sector was strength from Genie Energy Ltd. GNE and New Jersey Resources Corporation NJR.
In trading on Friday, energy dipped by 1.4%.
Top Headline
Foot Locker Inc reported better-than-expected Q3 results and raised FY22 guidance.
Foot Locker reported a third-quarter FY22 sales decline of 0.73% year-on-year to $2.17 billion, beating the consensus of $2.09 billion. Adjusted EPS of $1.27 beat the analyst consensus of $1.11. Comparable store sales increased 0.8% versus last year.
It raised adjusted FY22 EPS from $4.25 - $4.45 to $4.42 - $4.50.
Equities Trading UP
- PaxMedica, Inc. PXMD shares shot up 41% to $2.18. after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital.
- Shares of Clearfield, Inc. CLFD got a boost, shooting 27% to $118.07 after the company reported better-than-expected Q4 results.
- IVERIC bio, Inc. ISEE shares were also up, gaining 26% to $21.75 after the company announced the FDA has granted breakthrough therapy designation for avacincaptad pegol for geographic atrophy.
Equities Trading DOWN
- G1 Therapeutics, Inc. GTHX shares tumbled 24% to $6.51 after the company announced pricing of a $50.05 million public offering of 7.7 million shares of common stock at a price of $6.50 per share.
- Shares of Kiora Pharmaceuticals, Inc. KPRX were down 34% to $3.9305. Kiora Pharmaceuticals entered into agreements to raise $3.12 million from the exercise of previously issued Class A warrants.
- Inotiv, Inc. NOTV was down, falling 24% to $5.19. Lake Street downgraded Inotiv from Buy to Hold and announced a $7 price target. Inotiv, on Thursday, announced the U.S. Attorney's Office for the Southern District of Florida has criminally charged employees of the co.'s principal supplier of non-human primates, along with two Cambodian officials, with conspiring to illegally import non-human primates into the U.S.
Also check out: Hillenbrand, Cisco, Macy's And Other Big Gainers From Thursday
Commodities
In commodity news, oil traded down 3.4% to $78.83 while gold traded down 0.5% at $1,754.00.
Silver traded up 0.1% to $20.98 on Friday while copper fell 1.4% to $3.6360.
Euro zone
European shares closed higher today. The eurozone’s STOXX 600 gained 1.16%, London’s FTSE 100 rose 0.53% while Spain’s IBEX 35 Index rose 1.08%. The German DAX rose 1.16%, French CAC 40 climbed 1.04% and Italy’s FTSE MIB Index gained 1.38%.
Retail sales in the UK rose 0.6% month-over-month in October versus analysts’ expectations for a 0.3% growth, while the GfK Consumer Confidence indicator increased slightly to -44 in November.
Asia Pacific Markets
Asian markets closed lower on Friday, with the Japan’s Nikkei dropping 0.11% and Hong Kong’s Hang Seng Index falling 0.29%. China’s Shanghai Composite Index fell 0.58%.
The core consumer price index in Japan rose 3.6% from a year ago in October.
Economics
- Existing home sales in the US dropped 5.9% to an annual rate of 4.43 million in October, recording the lowest level since December.
- US leading economic index declined 0.8% in November.
- The total number of active U.S. oil rigs climbed by 1 to 623 rigs this week, Baker Hughes Inc reported.
Check out this: Market Volatility Decreases Following Jobless Claims Data
COVID-19 Update
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 100,108,700 cases with around 1,101,840 deaths. India confirmed a total of at least 44,668,950 cases and 530,550 deaths, while France reported over 37,250,370 COVID-19 cases with 158,080 deaths. In total, there were at least 642,113,850 cases of COVID-19 worldwide with more than 6,622,180 deaths.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.